Skin Neoplasms | Investigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer.

Skin Neoplasms research study

What is the primary objective of this study?

We will do systematic and functional assessment of non-melanoma skin cancer including precancerous lesions by OCT imaging and other diagnostic methods. The systematic assessment will be comparison of clinical diagnosis, histopathology, OCT images, spectrophotometry and high frequency ultrasound of non-melanoma skin cancer Functional exploration of non-melanoma skin cancer is done with Doppler-OCT and polarization-sensitive-OCT.

Who is eligible to participate?

Inclusion Criteria: - Patients above the age of 18 years with primary non-melanoma skin cancer NMSC or precancerous lesions from the Dermatology Department, and the Plastic Surgery Department at Roskilde Hospital, and from office based dermatologist in Roskilde County. Patients will only be recruited after informed consent. Exclusion Criteria: - Pregnancy. - To avoid the potential bias of scar tissue in the OCT images we will not include OCT images from recurrent NMSC in this study. - Patients will be excluded from the study if they are not able to give an informed consent. Staff from the Dermatology, Internal Medicine and Plastic Surgery Departments at RAS cannot be included in the phase I/phase 2 study. - Gender: both - Age limits: 18- no max

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Skin Neoplasms

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Device:optical coherence tomography

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Study Status

Unknown status

Start Date: February 2006

Completed Date: July 2008


Type: Observational


Primary Outcome:

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: Mette Mogensen, MD

Lead Sponsor: Zealand University Hospital


More information:

Discuss Skin cancer